| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
guanine monophosphate synthase | 0.769 | 0.269 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.100 | None | 0.965 | 227 | 1 | 1984 | 2020 | ||||||||
|
adenine phosphoribosyltransferase | 0.423 | 0.846 | 5.5E-13 |
|
disease | 0.300 | None | 1.000 | 16 | 0 | 1984 | 2019 | ||||||||
|
hypoxanthine phosphoribosyltransferase 1 | 0.500 | 0.808 | 0.94 |
|
disease | 0.220 | None | 1.000 | 3 | 0 | 1984 | 2009 | ||||||||
|
phosphoribosyl pyrophosphate amidotransferase | 0.705 | 0.385 | 0.99 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 1984 | 1993 | ||||||||
|
serpin family A member 7 | 0.641 | 0.615 | 2.6E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1984 | 1988 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 1984 | 2013 | ||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
glucosylceramidase beta pseudogene 1 | 0.623 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1984 | 1984 | |||||||||
|
complement factor I | 0.569 | 0.731 | 3.5E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
phosphoribosylformylglycinamidine synthase | 0.780 | 0.308 | 9.9E-18 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.985 | 131 | 0 | 1985 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 79 | 0 | 1985 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.985 | 67 | 3 | 1985 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.920 | 25 | 4 | 1985 | 2020 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1985 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 1.000 | 18 | 6 | 1985 | 2019 | ||||||||
|
retinol binding protein 4 | 0.493 | 0.808 | 0.52 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1985 | 2011 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1985 | 2018 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1985 | 2018 | ||||||||
|
SURP and G-patch domain containing 1 | 0.623 | 0.615 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1985 | 2019 | ||||||||
|
renin binding protein | 0.528 | 0.769 | 0.45 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1985 | 2006 | ||||||||
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 0.666 | 0.423 | 2.4E-03 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 1985 | 2016 | ||||||||
|
G protein-coupled receptor 162 | 0.631 | 0.654 | 9.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
apolipoprotein C2 | 0.606 | 0.577 | 0.40 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 |